PMV PHARMACEUTICALS, INC. Increase Decrease In Operating Lease Liability
PMV PHARMACEUTICALS, INC. (PMVP) reported Increase Decrease In Operating Lease Liability of $241.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2025-03-03
- PMV PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2024 was $241.00K, a 71.21% decline from fiscal 2023.
- PMV PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2023 was $837.00K, a 71.81% decline from fiscal 2022.
- PMV PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2022 was $2.97M.
| Period end | Increase Decrease In Operating Lease Liability 12 month |
|---|---|
| 2024-12-31 | $241.00K 10-K · filed 2025-03-03 |
| 2023-12-31 | $837.00K 10-K · filed 2025-03-03 |
| 2022-12-31 | $2.97M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |